论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhao J, Yun X, Ruan X, Chi J, Yu Y, Li Y, Zheng X, Gao M
Received 20 August 2018
Accepted for publication 31 December 2018
Published 18 February 2019 Volume 2019:12 Pages 1309—1318
DOI https://doi.org/10.2147/OTT.S184560
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Dr Federico Perche
Background: NUCB2, a
novel multifunctional protein containing several functional domains, was newly
found to play important roles in many cancers, but its role in papillary
thyroid cancer (PTC) is not well investigated. Therefore, our study was
performed to explore the functions of NUCB2 in PTC.
Methods: NUCB2
protein level was analyzed by immunohistochemistry. Data analyses were made by
performing chi-squared test. Quantitative reverse-transcription PCR, Western
blot, colony formation, MTT, and transwell invasion assays were performed to
test the expression levels and functions of NUCB2 in PTC.
Results: In PTC
tissues, NUCB2 protein expression level was positively correlated with
extrathyroidal extension, TNM stage, and tumor size of PTC patients.
In vitro experiments demonstrated that knockdown of NUCB2 using specific
shRNA for NUCB2 significantly impaired cell proliferation and invasion of PTC
cell lines. In vivo, silencing of NUCB2 inhibited the growth of tumors in
mice.
Conclusion: These
results suggested a novel function of NUCB2 in the process of proliferation and
invasion in PTC. NUCB2 may be considered a potent prognostic factor in PTC.
Keywords: NUCB2,
papillary thyroid cancer, proliferation, invasion